Skip to content
TrialScanner

NCT01260779

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

No phase registeredNo longer availablePVCTLead

Registry record

Lead sponsor
Provectus Biopharmaceuticals, Inc.
Conditions
Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory; Approved Alternative Therapy
Primary completion
Not registered
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01260779 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01260779: Expanded Access Protocol for... | TrialScanner